commercial sources include companies producing Actidose, Insta-char

Padagis is a leading pharmaceutical company specializing in the development, manufacturing, and distribution of generic topical and specialty products. Formed in 2021 following the acquisition of Perrigo's generic prescription business by Altaris Capital Partners, the company inherited a robust portfolio that includes Paddock Laboratories' legacy products. Among its key offerings is Actidose-Aqua, a prominent brand of activated charcoal used in emergency medicine for the treatment of acute poisoning. Padagis operates as a major player in the extended topicals market, providing a wide range of creams, ointments, and oral liquids. The company maintains significant manufacturing operations in the United States and Israel, focusing on high-quality, affordable generic alternatives. While Padagis produces Actidose, other commercial sources for similar products include companies like VistaPharm, which manufactures Insta-char.